Hetero Healthcare to supply 20,000 vials of Covifor (Remdesivir) across India
Covifor is the first generic brand of Remdesivir which is indicated for the treatment of COVID-19 patients in adults and children,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DCGI
Cipla launches remdesivir under brand name CIPREMI
The product will be in the form of lyophilised powder for injection 100 mg
Cipla, Hetero get DCGI nod to manufacture remdesivir
With this move, domestic production of remdesivir for “restricted emergency use” can begin
CDSCO to inspect BDR Pharma’s formulation facility, submit report in seven days
It is part of fast-tracking manufacturing and marketing applications of remdesivir, informs CDSCO
Umifenovir gets DCGI nod for Phase III clinical trial against COVID-19
CSIR-CDRI has developed the process technology for Umifenovir and licensed the process technology for manufacturing and marketing…
Telangana DCA issues approx 110 licenses for manufacturing hand sanitisers
Approves only those based on CDSCO-approved compositions
Sun Pharma initiates Phase II clinical trial on AQCH as potential treatment for COVID-19
AQCH is the first phytopharmaceutical drug approved for clinical trial by DCGI for COVID-19 and has shown anti-SARS-CoV-2 effects…
Remdesivir approved for use in treatment of severe COVID-19 patients
The injectable medicine has been allowed for administration as part of a maximum five-day regimen
CDSCO to procure data on stock position of medical oxygen for 18 months
It has issued a list of 26 medical oxygen manufacturers from across the country and asked for several details to be furnished by…
Biocon Biologics gets DCGI approval for emergency use of CytoSorb to treat critical COVID-19…
US FDA recently approved CytoSorb for emergency use in COVID-19 patients